Circling the Wagons
Executive Summary
Whither Japan Pharma? If the last quarter's dealmaking is any hint, it's sticking pretty close to home--indeed, circling the wagons. An industry that needs to become less conservative is doing just the opposite as cost pressures increase in its home market.